Cargando…
Reversible Covalent PROTACs: Novel and Efficient Targeted Degradation Strategy
The proteolysis targeting chimeras (PROTACs), which are composed of a target protein binding moiety, a linker, and an E3 ubiquitin ligase binder, have been a promising strategy for drug design and discovery. Given the advantages of potency, selectivity, and drug resistance over inhibitors, several P...
Autores principales: | Yuan, Minghua, Chu, Yanan, Duan, Yongtao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287302/ https://www.ncbi.nlm.nih.gov/pubmed/34291036 http://dx.doi.org/10.3389/fchem.2021.691093 |
Ejemplares similares
-
Efficient
Targeted Degradation via Reversible and
Irreversible Covalent PROTACs
por: Gabizon, Ronen, et al.
Publicado: (2020) -
Correction to Efficient Targeted Degradation via Reversible
and Irreversible Covalent PROTACs
por: Gabizon, Ronen, et al.
Publicado: (2020) -
Targeting Protein Kinases Degradation by PROTACs
por: Yu, Fei, et al.
Publicado: (2021) -
Bromodomain and BET family proteins as epigenetic targets in cancer therapy: their degradation, present drugs, and possible PROTACs
por: Muddassir, Mohd., et al.
Publicado: (2020) -
Light-mediated multi-target protein degradation using arylazopyrazole photoswitchable PROTACs (AP-PROTACs)
por: Zhang, Qisi, et al.
Publicado: (2022)